导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.15% | 279/1050 |
| 近一周 | -1.75% | 302/1104 |
| 近一月 | -1.26% | 166/1102 |
| 近一季 | -3.77% | 383/1092 |
| 近半年 | 0.05% | 417/1070 |
| 近一年 | 19.90% | 238/1018 |
| 近两年 | 33.97% | 646/926 |
| 近三年 | 11.40% | 584/834 |
| 成立以来 | 96.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.06% 255/1070 |
14.11% 466/1101 |
- - |
- - |
| 2025 | 10.85% 819/1065 |
-3.39% 970/1014 |
0.97% 614/1038 |
6.82% 906/1050 |
6.38% 95/1065 |
| 2024 | -4.84% 702/1011 |
-2.51% 446/960 |
0.24% 291/983 |
4.09% 906/991 |
-6.46% 754/1011 |
| 2023 | -12.30% 409/952 |
1.88% 519/880 |
-7.55% 672/895 |
-2.50% 180/915 |
-4.50% 454/952 |
| 2022 | -19.68% 315/867 |
-18.25% 444/773 |
10.49% 244/806 |
-9.68% 226/845 |
-1.55% 515/867 |
| 2021 | 13.02% 207/740 |
-3.94% 303/580 |
17.57% 194/659 |
-3.91% 310/704 |
4.16% 256/740 |
| 2020 | 92.32% 52/554 |
-1.74% 208/419 |
32.09% 98/466 |
23.38% 26/517 |
20.09% 116/554 |
| 2019 | 51.11% 140/410 |
26.80% 562/1146 |
3.81% 82/1228 |
5.56% 192/390 |
8.75% 209/410 |
| 2018 | -33.33% 255/349 |
- - |
-13.18% 671/990 |
-11.41% 836/1000 |
-14.42% 851/1080 |
| 2017 | 11.27% 128/285 |
- - |
- - |
- - |
- - |
| 2016 | -12.39% 80/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇添富国企创新股票A VS. 东吴新产业精选股票A(580008) |